Kimberly-Clark bid to buy Tylenol maker, and other acquisitions push deal boom toward $4 trillion
CNBC TV18 CNBC TV18

Kimberly-Clark bid to buy Tylenol maker, and other acquisitions push deal boom toward $4 trillion

Investment bankers have bounced back from a rocky start to 2025 and are now well on course for their best year since 2021, data compiled by Bloombe...
Summarized by AI
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.